A controlled study of flufenamic acid in ankylosing spondylitis. A final report and follow-up study.
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D002214:Capsules; D002908:Chronic Disease; D005260:Female; D005439:Flufenamic Acid / Q000009:adverse effects / Q000627:therapeutic use; D005461:Fluorine / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D010653:Phenylbutazone / Q000009:adverse effects / Q000627:therapeutic use*; D013167:Spondylitis, Ankylosing / Q000188:drug therapy*; D000637:Transaminases / Q000097:blood; D062367:ortho-Aminobenzoates / Q000627:therapeutic use*
D000893:Anti-Inflammatory Agents; D002214:Capsules; D062367:ortho-Aminobenzoates; D005461:Fluorine; D005439:Flufenamic Acid; D000637:Transaminases; D010653:Phenylbutazone